{"chebi_id":"91435","chebi_name":"linifanib","chebi_synonyms":["linifanibum","1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea","ABT869","N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea","ABT 869","ABT-869"],"diffprof_id_observed":["MTBLS4967_0001_00000003"],"diffprof_id_var_observed":[],"inchikey":"MPVGZUGXCQEXTM-UHFFFAOYSA-N","inn_name":"linifanib","iupac_name":"","num_study_observed":1,"reactome_ids":["R-HSA-1280215","R-HSA-1643685","R-HSA-168256","R-HSA-5663202","R-HSA-9607240","R-HSA-9682385","R-HSA-9702506","R-HSA-9702509","R-HSA-9702998"],"reactome_names":["Cytokine Signaling in Immune system","Disease","Immune System","Diseases of signal transduction by growth factor receptors and second messengers","FLT3 Signaling","FLT3 signaling in disease","Drug resistance of FLT3 mutants","FLT3 mutants bind TKIs","linifanib-resistant FLT3 mutants"],"study_id_observed":["MTBLS4967"],"study_id_var_observed":[],"synonym_name":"<em>N</em>-[4-(3-amino-1<em>H</em>-indazol-4-yl)phenyl]-<em>N</em>'-(2-fluoro-5-methylphenyl)urea"}